Publications Database

Awad G. A. (1996)

The use of selective serotonin reuptake inhibitors in young children with pervasive developmental disorders: some clinical observations.

Canadian Journal of Psychiatry

August, 41(6), pp. 361-366

Read Abstract (New Window)

Buitelaar J. K. , van der Gaag R. J. , van der Hoeven J. (1998)

Buspirone in the management of anxiety and irritability in children with pervasive developmental disorders: Results of an open-label study.

Journal of Clinical Psychiatry

59(2), pp. 56-59

Read Abstract (New Window)

Chugani D. C. et al. (2016)

Efficacy of low-dose buspirone for restricted and repetitive behavior in young children with autism spectrum disorder: A randomized trial.

Journal of Pediatrics

March, 170 pp. 45-53.

Read Abstract (New Window) Read Full (New Window)

Doyle C. A. , McDougle C. J. (2012)

Pharmacotherapy to control behavioral symptoms in children with autism.

Expert Opinion on Pharmacotherapy

13(11), pp. 1615-1629.

Read Abstract (New Window)

Fayyazi A. et al. (2014)

A comparison of risperidone and buspirone for treatment of behavior disorders in children with phenylketonuria.

Iranian Journal of Child Neurology

Fall, 8(4), pp. 33-38.

Read Abstract (New Window) Read Full (New Window)

Masi G. (2004)

Pharmacotherapy of pervasive developmental disorders in children and adolescents.

CNS Drugs

18(14), pp. 1031-1052

Read Abstract (New Window)

Orsagh-Yentis D. K. et al. (2011)

Buspirone for bruxism in a child with pervasive developmental disorder-not otherwise specified

Journal of Child and Adolescent Psychopharmacology

Read Abstract (New Window)

American Society of Health-System Pharmacists (2011)

Buspirone.

Bethesda, MD: American Society of Health-System Pharmacists

Read Full (New Window)

Posey D. J. , McDougle C. J. (2000)

The pharmacotherapy of target symptoms associated with autistic disorder and other pervasive developmental disorders.

Harvard Review of Psychiatry

8(2), pp. 45-63

Read Abstract (New Window)

Realmuto G. , August G. , Garfinkel B. (1989)

Clinical effect of buspirone in autistic children.

Journal of Clinical Psychopharmacology

9(2), pp. 122-125

Read Abstract (New Window)

Riddle M. A. et al. (1999)

Anxiolytics, adrenergic agents, and naltrexone.

Journal of the American Academy of Child and Adolescent Psychiatry

38(5), pp. 546-556

Read Abstract (New Window)

Tsai L. Y. (1999)

Psychopharmacology in autism.

Psychosomatic Medicine

61(5), pp. 651-665

Read Abstract (New Window) Read Full (New Window)

Vasa R. A. et al. (2014)

A systematic review of treatments for anxiety in youth with autism spectrum disorders.

Journal of Autism and Developmental Disorders

December, 44(12), pp. 3215-3229.

Read Abstract (New Window)